Aurinia Pharmaceuticals Inc. News - AUP

Best deals to access real time data!
TSX Level 1
Monthly Subscription
for only
$15.00
Canadian Level 1 + USA
Monthly Subscription
for only
$34.59
North American Extreme
Monthly Subscription
for only
$95.00
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Aurinia Pharmaceuticals AUP Toronto Common Stock CA05156V1022
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.17 +2.46% 7.09 7.16 6.95 6.96 6.92 15:11:01
more quote information »

Recent News

Date Time Source Heading
2/22/201815:07BWAurinia Enhances Research, Development, & Scientific..
2/20/201815:01BWAurinia Named Company of the Year by LifeSciences BC
2/14/201807:00BWAurinia Pharmaceuticals Launches New Lupus Nephritis Disease..
2/08/201807:00BWAurinia Enhances Commercial and Business Development..
2/06/201807:00BWAurinia to Present at Leerink Partners 7th Annual Global..
1/04/201815:37BWAurinia Pharmaceuticals Files New Preliminary Base Shelf..
12/11/201715:02BWAurinia Pharmaceuticals Added to the NASDAQ Biotech Index
11/14/201715:00BWAurinia Reports Third Quarter 2017 Financial Results and..
11/06/201715:05BWAurinia Pharmaceuticals to Release Third Quarter 2017..
10/20/201707:00BWAurinia to Expand Renal Franchise with Novel Indications and..
10/12/201706:00BWAurinia Receives National Corporate Visionary Award from the..
9/19/201715:01BWAurinia to Host R&D Day and Webcast on October 20th in New..
9/08/201716:45PRNCAS&P Dow Jones Indices Announces Changes to the S&P/TSX..
9/08/201716:42PRNCAS&P Dow Jones Indices annonce des modifications aux indices..
9/05/201712:05BWAurinia to Webcast at Upcoming Investor Conferences
8/10/201715:30BWAurinia Reports Second Quarter 2017 Financial Results, and..
7/12/201720:15BWAurinia Resolves Temporary Non-Compliance with Nasdaq’s..
6/22/201715:30BWAurinia Announces Results of Annual General Meeting
6/21/201706:00BWAurinia to Host Annual General Meeting of Shareholders and..
6/16/201706:58BWVoclosporin Remission Data from the Phase IIb AURA-LV Study..
6/05/201710:27BWAurinia Presents Additional Data from Phase IIB AURA-LV..
6/05/201707:00BWAurinia Presents Additional Data from Phase Iib Aura-Lv..
5/30/201715:19BWAurinia to Participate in Late Breaking Oral Presentations..
5/17/201715:02BWAurinia Doses First Patient in AURORA Phase 3 Clinical Trial..
5/15/201707:00BWAurinia Reports First Quarter 2017 Financial Results,..
5/09/201707:00BWPharma Industry Veteran Dr. George Milne Joins Aurinia’s..
4/26/201712:03BWAurinia to Present at Bloom Burton & Co. Healthcare..
4/26/201708:17BWAurinia to Present at Bloom Burton & Co. Healthcare..
4/20/201716:00BWAurinia Releases Additional 48-Week Data from the AURA-LV..
4/17/201715:02BWAurinia Completes Licensing Deal with Merck Animal Health..
4/06/201716:12BWAurinia Announces Development Plans for Voclosporin in..
3/27/201702:30BWAurinia Highlights 48-Week Data from Open-Label AURION Study..
3/20/201715:05BWAurinia Closes US$173.1 Million Public Offering of Common..
3/16/201715:01BWAurinia Announces Presentation at 12th International..
3/14/201707:00BWAurinia Prices US$150.5 Million Public Offering of Common..
3/13/201715:01BWAurinia Announces Public Offering of Common Shares
3/09/201707:30BWAurinia Reports Fourth Quarter and Full Year 2016 Financial..
3/06/201715:05BWAurinia Announces Acceptance of Voclosporin Late-Breaking..
3/02/201712:12BWAurinia to Present at Cowen and Company 37th Annual..
3/01/201715:05BWAurinia Announces Voclosporin Meets 48-Week Remission..
See more news about this stock »
Your Recent History
TSX
BCE
BCE Inc
TSX
IVN
Ivanhoe Mi..
FX
CADUSD
Canadian D..
USOTC
XUII
Xumanii In..
FX
EURCAD
Euro vs Ca..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20180225 17:37:41